Safety, Provider Evaluation, and Who Should Consider This Treatment Before initiating semaglutide or any GLP-1 therapy post-bariatric surgery, your provider must assess: time since surgery (typically 1-2 years minimum), nutritional status and supplementation compliance, history of dumping syndrome or gastroparesis, and current medication interactions
Finally, Tirzepatide is a dual GIP and GLP-1R agonist that stimulates both receptors, potentially offering greater metabolic benefits than GLP-1 agonism alone and enabling mechanistic interplay studies
Additionally, female patients and those identifying as Black/African-American demonstrated higher return rates to the ED
too much, and our cells can grow out of control, leading to cancer and potentially, premature aging
Our team works closely with patients to provide education, monitoring, and personalized guidance, helping ensure weight-loss goals are supported safely and effectively within a comprehensive care plan
Regularly consuming hydroxytyrosol-rich foods or supplements can help maintain optimal levels in your body over time
